Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

333
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

254
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
254
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

726
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
726
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

291
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
291
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

333
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
333
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

3.2K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute capillary blood DNA methylation responses to swimming exercise in high-performance male and female swimmers.

Experimental physiology·2026
Same author

Training load influences gut microbiome of highly trained rowing athletes.

Journal of the International Society of Sports Nutrition·2025
Same author

How I treat iron-refractory iron deficiency anaemia-An expert opinion-based treatment guidance for children and adults.

British journal of haematology·2025
Same author

Does chronic oral contraceptive use detrimentally affect C-reactive protein or iron status for endurance-trained women?

Physiological reports·2023
Same author

Improving menstrual health literacy in sport.

Journal of science and medicine in sport·2023
Same author

The role of exercise and hypoxia on glucose transport and regulation.

European journal of applied physiology·2023

Related Experiment Video

Updated: Mar 23, 2026

Evaluation of Blood Lactate and Plasma Insulin During High-intensity Exercise by Antecubital Vein Catheterization
04:28

Evaluation of Blood Lactate and Plasma Insulin During High-intensity Exercise by Antecubital Vein Catheterization

Published on: May 18, 2018

7.0K

Live high, train low - influence on resting and post-exercise hepcidin levels.

A D Govus1, P Peeling2, C R Abbiss3

  • 1Institute for Sport & Physical Activity Research, University of Bedfordshire, Bedford, UK.

Scandinavian Journal of Medicine & Science in Sports
|April 3, 2016
PubMed
Summary

Prolonged hypoxic exposure suppresses resting hepcidin levels. However, the post-exercise hepcidin response remains unchanged following endurance training in normoxia and hypoxia.

Keywords:
Iron metabolismaltitude traininghypoxiairon deficiency

More Related Videos

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.9K
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.7K

Related Experiment Videos

Last Updated: Mar 23, 2026

Evaluation of Blood Lactate and Plasma Insulin During High-intensity Exercise by Antecubital Vein Catheterization
04:28

Evaluation of Blood Lactate and Plasma Insulin During High-intensity Exercise by Antecubital Vein Catheterization

Published on: May 18, 2018

7.0K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.9K
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.7K

Area of Science:

  • Exercise Physiology
  • Altitude Training
  • Iron Metabolism

Background:

  • The impact of prolonged hypoxic exposure on post-exercise hepcidin response is not well-defined.
  • Hepcidin plays a crucial role in iron regulation, influencing iron availability for red blood cell production.

Purpose of the Study:

  • To investigate the effects of 14 days of normobaric hypoxia on resting and post-exercise hepcidin levels in well-trained runners.
  • To compare exercise-induced hepcidin responses in normoxia and hypoxia before and after a period of hypoxic exposure.

Main Methods:

  • 10 well-trained distance runners completed high-intensity exercise protocols in normoxia and normobaric hypoxia (3000m simulated altitude).
  • Plasma hepcidin concentrations were measured 3 hours post-exercise and after 2 and 14 days of hypoxic exposure.
  • Hemoglobin mass was assessed before and after the 14-day hypoxic period.

Main Results:

  • Two weeks of normobaric hypoxia significantly suppressed resting hepcidin levels.
  • The post-exercise hepcidin increase was observed in both normoxia and hypoxia, and this response was not altered by the hypoxic exposure.
  • No significant changes in hemoglobin mass were reported after the 14-day hypoxic exposure.

Conclusions:

  • Normobaric hypoxia for 2 weeks suppresses resting hepcidin.
  • The acute exercise-induced hepcidin response is maintained during and after prolonged hypoxic exposure.
  • These findings suggest that the body adapts to maintain iron homeostasis during exercise under hypoxic conditions.